The nociceptin receptor as a potential target in drug design

Drug News and Perspectives

Volumn 14, Issue 6, 2001, Pages 335-345

  Smith, P A ^a   Moran, T D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 8 (ACENAPHTHEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; ANALGESIC AGENT; BINALTORPHIMINE; DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIURETIC AGENT; ENDOMORPHIN 1; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTRINDOLE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; OPIATE RECEPTOR 4; RO 646198; SUFENTANIL; UNCLASSIFIED DRUG;

ANOREXIA; ANXIETY; BRAIN ISCHEMIA; DRUG DEPENDENCE; DRUG MECHANISM; DRUG SYNTHESIS; EPILEPSY; GASTROINTESTINAL MOTILITY; HUMAN; HYPERTENSION; IMPOTENCE; MEMORY; NEUROGENIC BLADDER; NOCICEPTION; PAIN; REVIEW; SPINAL ANESTHESIA;

EID: 0034796951     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Pharmacology of nociceptin and its receptor: A novel therapeutic target
2. International Union of Pharmacology. XII. Classification of opioid receptors
3. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
4. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
5. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
6. Cellular actions of nociceptin: Transduction mechanisms
7. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ
8. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids
9. Morphine-like drugs inhibit stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate
10. Enkephalin opens potassium channels on mammalian central neurones
11. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes
12. Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons
13. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels
14. On the potassium conductance increased by opioids in rat locus coeruleus neurones
15. Kappa-opioid receptors also increase potassium conductance
16. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro
17. Comparison of the actions of morphine-3-d-glucuronide, DAMGO and nociceptin on rat substantia gelatinosa neurons
18. Increase by the ORL1 receptor (opioid receptorlike1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe neurones
19. Inhibition of calcium currents by noradrenaline, somatostatin and opioids in guinea-pig submucosal neurones
20. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons
21. Mu-opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons
22. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons
23. Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism
24. Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord
25. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons
26. Pre- and postsynaptic inhibition by opioids in rat striatum
27. Modulation of Ca2+ channel currents in acutely dissociated rat periaqueductal grey neurons
28. Mu-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in the guinea pig and rat
29. Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor
30. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist
31. Cloning and functional comparison of kappa- and delta-opioid receptors from mouse brain
32. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
33. Cloning of a delta opioid receptor by functional expression
34. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors
35. cDNA cloning of an orphan opiate receptor gene family member and its splice variant
36. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type
37. cDNA cloning and regional distribution of a novel member of the opioid receptor family
38. Structure and chromosomal mapping of genes for the mouse kappa-opioid receptor and an opioid receptor homologue (MOR-C)
39. Nociceptin/orphanin FQ receptor ligands
40. The nociceptin (ORL1) receptor: Molecular cloning and functional architecture
41. The orphanin FQ/nociceptin gene: Structure, tissue distribution of expression and functional implications obtained from knockout mice
42. Structure tissue distribution, and chromosomal localization of the prepronociceptin gene
43. Primary structure and tissue distribution of the orphanin FQ precursor
44. Nocistatin: A novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor
45. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor
46. Nociceptin Phel-nociceptin1-13, nocistatin and prepronociceptin154-181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro
47. Nocistatin, a peptide that blocks nociceptin action in pain transmission
48. Effect of nocistatin and its interaction with nociceptin/orphanin FQ on the rat formalin test
49. Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia
50. Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices
51. Nociceptin/orphanin FQ metabolism: Role of aminopeptidase and endopeptidase 24.15
52. Nociceptin/orphanin FQ metabolism and bioactive metabolites
53. Functional antagonism of mu-, delta- and kappa-opioid receptors by orphanin FQ
54. Orphanin FQ is a functional anti-opioid peptide
55. Effects of supraspinal orphanin FQ/nociceptin
56. Antagonistic action of orphanin FQ on acupuncture analgesia in rat brain
57. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: Antagonism in brain and potentiation in spinal cord of the rat
58. Functional blockade of opioid analgesia by orphanin FQ/nociceptin
59. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor
60. Cellular neurophysiological actions of nociceptin/orphanin FQ
61. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat paramedical gray neurons in vitro
62. Neurotransmitters in nociceptive modulatory circuits
63. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventrolateral medulla
64. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin
65. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test
66. Anti-hyperalgesic and antiallodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation
67. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice
68. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments
69. Orphanin FQ (nociceptin) modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, and blocks the substance P-induced facilitation of N-methyl-D-aspartate-evoked responses
70. Effects of intrathecal orphanin FQ on a flexor reflex in the rat after inflammation or peripheral nerve section
71. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat
72. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro
73. Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord
74. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin
75. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat in vivo
76. Actions of morphine 3-glucuronide on membrane properties and synaptic transmission in rat substantia gelatinosa neurons in vitro
77. Postsynaptic K+ current induced by nociceptin in medullary dorsal horn neurons
78. The effect of RFamide-related peptides and nociceptin on electrical activity recorded from isolated rat spinal cord
79. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord
80. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice
81. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
82. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
83. Orphanin FQ, agonist of orphan opioid receptor ORL1, simulates feeding in rats
84. Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors
85. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
86. [Nphe(1)]-nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats
87. Role of nociceptin systems in learning and memory
88. Orphanin FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons
89. Nociceptin (orphanin FQ), an endogenous ligand for the ORL1 (opioid-receptor-like 1), modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli
90. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus
91. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms
92. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: Calcium current reduction
93. Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus
94. The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line
95. Nociceptin receptor-mediated Ca2+ channel inhibition and its desensitization in NG108-15 cells
96. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors
97. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin
98. Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices
99. Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices
100. Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones
101. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats
102. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
103. Nociceptin/orphanin FQ drugs of abuse
104. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat
105. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat
106. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat
107. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat
108. Nociceptin has vasodilator activity in the pulmonary vascular bed of the rat
109. Characterization of nociceptin receptors in the periphery: In vitro and in vivo studies
110. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats
111. Cardiovascular effects of nociceptin in unanesthetized mice
112. Studies of the cardiovascular effects of nociceptin and related peptides
113. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep
114. Neurohumoral effects of orphanin FQ/nociceptin: Relevance to cardiovascular and renal function
115. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats
116. Profound inhibition of cardiomotor neurons in the rat rostral ventrolateral medulla by nociceptin (orphanin FQ)
117. Nociceptin: An endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties
118. Analysis of vasodepressor responses to nociceptin and nociceptin analogs in the systemic vascular bed of the anesthetized rabbit in vivo
119. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves
120. ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery
121. Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and K(ca) channel activation
122. Nociceptin, a novel endogenous ligand for the ORL1 receptor, has potent erectile activity in the cat
123. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens
124. Orphanin FQ/nociceptin: A novel neuromodulator of gastrointestinal function?
125. Functional significance of a newly discovered neuropeptide, orphanin FQ, in rat gastrointestinal motility
126. Peripheral and central actions of orphanin FQ (nociceptin) on murine colon
127. The mouse vas deferens: A pharmacological preparation sensitive to nociceptin
128. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites
129. Cloning expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract
130. The effect of nociceptin, an endogenous ligand for the ORL1 receptor, on rat colonic contraction and transit
131. Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea pig bronchus
132. Nociceptin effects in the airways
133. Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus
134. Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway
135. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
136. Inhibition of rat oxytocin and vasopressin supraoptic nucleus neurons by nociceptin in vitro
137. Activation of an inwardly-rectifying K+ conductance by orphanin-FQ/nociceptin in vasopressin-containing neurons
138. Nociceptin and the micturition reflex
139. Multiple sites of action in the inhibitory effect of nociceptin on the micturition reflex
140. Nociceptin protects capsaicinsensitive afferent fibers in the rat urinary bladder from desensitization
141. The inhibitory effect of nociceptin on the micturition reflex in anaesthetized rats
142. Cutting edge: Nociceptin stimulates neutrophil chemotaxis and recruitment: Inhibition by aspirin-triggered-15-epi-lipoxin a(4)
143. Species differences in the efficacy of compounds at the nociceptin receptor (ORL1)
144. 8-Acenaphthen-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists
145. High-affinity non-peptide agonists for the orl1 (orphanin FQ/nociceptin) receptor
146. ORL1 receptor ligands: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones
147. A Synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
148. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl] -3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J113397)
149. Nociceptin/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions
150. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
151. The hyperphagic effect of nociceptin/orphanin FQ in rats